Bpl overview
•Download as PPTX, PDF•
0 likes•13 views
The document describes Biopharma Patent Landscapes, a company that maintains a proprietary database tracking patents, exclusivities, and other intellectual property information for biopharmaceutical drugs. The database can be used to generate reports on loss of exclusivity dates, freedom to operate analyses, and visualizations of patent protections to help biopharma companies, investors, analysts, and litigation firms with strategic decision making and competitive intelligence. Biopharma Patent Landscapes offers on-demand landscape reports and continuously updates the database as new drugs are approved or patents are filed.
Report
Share
Report
Share
Recommended
Expressive RFID data access policies for the Pharmaceuticals supply chain
This document discusses approaches to securing the US pharmaceutical supply chain using RFID and electronic pedigree. It describes threats like counterfeit drugs entering the supply chain. The US market has over 1,400 manufacturers, 70 distributors and 166,000 pharmacies. The industry uses barcodes currently but RFID is also compatible. There are different models for pedigree like point-of-dispense authentication (PoD), document-based electronic pedigree (DeP), and network-centric electronic pedigree (NeP). PoD stores the least data while DeP stores the most and requires more secure connections. NeP provides a middle ground between the two. The document advocates starting with PoD and evolving to a full pedigree later.
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
After years of relatively easy blockbuster profits, worldwide respect and investment, and loyal customer bases, branded pharmaceutical companies are in trouble, increasingly vulnerable to the threats posed by the competition.
And who is that competition? It’s not other branded companies any more. Generics have emerged as the primary challenger to pharmaceutical industry success, offering a public hungry for medications and reduced costs exactly what they want and need. Generics have exploded in the last decades, and are poised for even bigger growth.
The situation is grim. It can seem like pharmaceutical companies have no recourse in the face of the lower prices and operating costs of the generics industry, and fortunes will only continue to fade.
But options do exist for pharmaceutical companies to mount an effective defense strategy against the threats posed by generics.
In this report, we examine some of these defensive strategies. We analyze the environment for pharmaceuticals today, as well as the generic industry as a whole.
We describe the pros and cons of legal defensive strategies, as well as opportunities to expand the revenue-generating product life cycle into reformulations and over-the-counter medications.
We look at pricing strategies, as well as company organizational changes as part of an integrated defense strategy.
And to help companies make tough decisions about the best defense, we examine powerful analytics techniques and case studies.
biotech
The document recommends an overweight position in the healthcare biotechnology industry. Major companies are seeing double digit revenue growth and high profit margins due to limited competition from patents. However, government regulation poses a threat if it imposes price caps or reduces patent lives. Additionally, companies rely on a small number of "star drugs" whose expiration or replacement could significantly harm their value.
Patent cliff
The document discusses the patent cliff that the pharmaceutical industry will face between 2012-2015 as many blockbuster drugs lose patent protection. An estimated $250 billion in annual drug sales will go off-patent during this time period, threatening the business models of major pharmaceutical companies. Generic drug manufacturers are expected to capture a significant share of the market. Companies are pursuing strategies like mergers and acquisitions, expanding into emerging markets, developing new drug pipelines, and patent litigation to mitigate the financial impact of losing drug exclusivity during this period.
patent cliff 2013-2015
The document discusses the patent cliff that the pharmaceutical industry will face between 2012-2015 as many blockbuster drugs lose patent protection. An estimated $250 billion in annual drug sales will go off-patent, severely impacting company revenues. Major companies are preparing by making acquisitions, cutting costs, expanding into new markets, and developing new drug pipelines. While generics will see significant growth, brand companies are pursuing strategies like authorized generics and patent litigation to minimize revenue losses from the patent cliff.
Medical Cannabis Investor Tool
The document discusses analyzing patent data to provide business intelligence for medical cannabis investors, including an overview of major cannabis companies' intellectual property portfolios, examples of IP litigation in the cannabis industry, trends in medical cannabis patent filings worldwide, and strategies for integrating different types of intellectual property protections like patents, trademarks, and plant breeders' rights.
Alitair presentation august 7 2017
The document is a presentation from Alitair Pharmaceuticals outlining their portfolio of drug development programs and investment opportunity. It summarizes that Alitair has technologies and drug candidates targeting large existing markets for opioid overdose reduction, chronic cough, and bronchiectasis. It is seeking $30 million investment over 18-30 months to advance these programs through clinical milestones to position the assets for partnership or monetization opportunities. The presentation provides details on the clinical development status and commercial potential of each program.
Medical Devices: Acquisitions Driving Growth
The document summarizes key mergers and acquisitions that occurred in the medical device market in 2014 and early 2015 according to a report by Kalorama Information. Several large companies acquired other companies to expand their product portfolios and market share in response to modest revenue growth in the medical device market. Notable acquisitions included BD acquiring CareFusion, Medtronic acquiring Covidien, Zimmer acquiring Biomet, and Thermo Fisher acquiring Life Technologies. The mergers were aimed at boosting revenues through increased market presence, new technologies, and access to new markets.
Recommended
Expressive RFID data access policies for the Pharmaceuticals supply chain
This document discusses approaches to securing the US pharmaceutical supply chain using RFID and electronic pedigree. It describes threats like counterfeit drugs entering the supply chain. The US market has over 1,400 manufacturers, 70 distributors and 166,000 pharmacies. The industry uses barcodes currently but RFID is also compatible. There are different models for pedigree like point-of-dispense authentication (PoD), document-based electronic pedigree (DeP), and network-centric electronic pedigree (NeP). PoD stores the least data while DeP stores the most and requires more secure connections. NeP provides a middle ground between the two. The document advocates starting with PoD and evolving to a full pedigree later.
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
After years of relatively easy blockbuster profits, worldwide respect and investment, and loyal customer bases, branded pharmaceutical companies are in trouble, increasingly vulnerable to the threats posed by the competition.
And who is that competition? It’s not other branded companies any more. Generics have emerged as the primary challenger to pharmaceutical industry success, offering a public hungry for medications and reduced costs exactly what they want and need. Generics have exploded in the last decades, and are poised for even bigger growth.
The situation is grim. It can seem like pharmaceutical companies have no recourse in the face of the lower prices and operating costs of the generics industry, and fortunes will only continue to fade.
But options do exist for pharmaceutical companies to mount an effective defense strategy against the threats posed by generics.
In this report, we examine some of these defensive strategies. We analyze the environment for pharmaceuticals today, as well as the generic industry as a whole.
We describe the pros and cons of legal defensive strategies, as well as opportunities to expand the revenue-generating product life cycle into reformulations and over-the-counter medications.
We look at pricing strategies, as well as company organizational changes as part of an integrated defense strategy.
And to help companies make tough decisions about the best defense, we examine powerful analytics techniques and case studies.
biotech
The document recommends an overweight position in the healthcare biotechnology industry. Major companies are seeing double digit revenue growth and high profit margins due to limited competition from patents. However, government regulation poses a threat if it imposes price caps or reduces patent lives. Additionally, companies rely on a small number of "star drugs" whose expiration or replacement could significantly harm their value.
Patent cliff
The document discusses the patent cliff that the pharmaceutical industry will face between 2012-2015 as many blockbuster drugs lose patent protection. An estimated $250 billion in annual drug sales will go off-patent during this time period, threatening the business models of major pharmaceutical companies. Generic drug manufacturers are expected to capture a significant share of the market. Companies are pursuing strategies like mergers and acquisitions, expanding into emerging markets, developing new drug pipelines, and patent litigation to mitigate the financial impact of losing drug exclusivity during this period.
patent cliff 2013-2015
The document discusses the patent cliff that the pharmaceutical industry will face between 2012-2015 as many blockbuster drugs lose patent protection. An estimated $250 billion in annual drug sales will go off-patent, severely impacting company revenues. Major companies are preparing by making acquisitions, cutting costs, expanding into new markets, and developing new drug pipelines. While generics will see significant growth, brand companies are pursuing strategies like authorized generics and patent litigation to minimize revenue losses from the patent cliff.
Medical Cannabis Investor Tool
The document discusses analyzing patent data to provide business intelligence for medical cannabis investors, including an overview of major cannabis companies' intellectual property portfolios, examples of IP litigation in the cannabis industry, trends in medical cannabis patent filings worldwide, and strategies for integrating different types of intellectual property protections like patents, trademarks, and plant breeders' rights.
Alitair presentation august 7 2017
The document is a presentation from Alitair Pharmaceuticals outlining their portfolio of drug development programs and investment opportunity. It summarizes that Alitair has technologies and drug candidates targeting large existing markets for opioid overdose reduction, chronic cough, and bronchiectasis. It is seeking $30 million investment over 18-30 months to advance these programs through clinical milestones to position the assets for partnership or monetization opportunities. The presentation provides details on the clinical development status and commercial potential of each program.
Medical Devices: Acquisitions Driving Growth
The document summarizes key mergers and acquisitions that occurred in the medical device market in 2014 and early 2015 according to a report by Kalorama Information. Several large companies acquired other companies to expand their product portfolios and market share in response to modest revenue growth in the medical device market. Notable acquisitions included BD acquiring CareFusion, Medtronic acquiring Covidien, Zimmer acquiring Biomet, and Thermo Fisher acquiring Life Technologies. The mergers were aimed at boosting revenues through increased market presence, new technologies, and access to new markets.
2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp
This document provides information about the "2nd Pharmaceutical Anti-counterfeiting Americas" conference taking place on November 14-15, 2011 in Boston, USA. The conference will discuss combating counterfeit medicines and feature speakers from pharmaceutical companies and regulatory agencies. Attendees will learn about US policy updates, technologies for tracking pharmaceuticals, and best practices for supply chain integrity. Posters can be submitted by academic institutions, pharmaceutical companies, and service providers to share research results. The conference is aimed at professionals working in pharmaceutical supply chain security, anti-counterfeiting, brand protection, and related fields.
Biotech & Pharma Market July 2009
The document discusses opportunities in the Indian pharmaceutical and biotechnology sectors. It outlines 8 subsectors: pharmaceuticals, biopharma, contract research organizations, industrial enzymes, agribiotech, bioinformatics, diagnostics, and lab supplies. The core pharmaceutical industry focuses on small molecule drugs and generics. The biotech industry includes bio-pharma, agriculture, bioinformatics and is growing at 30% annually. The Indian pharma/biotech market was estimated at $18 billion in 2008-2009 and is projected to continue strong growth across subsectors.
Tr The Pharma Matters
The report provides an overview of the US generics drug market for the third quarter of 2009. It discusses key trends in the market including growth rates globally and in major countries. It also analyzes the companies receiving the most ANDA approvals for generic drugs and those filing the most patent challenges during this period. Teva received the most ANDA approvals while Teva continued to file the most patent challenges. The report aims to provide strategic intelligence on companies making an impact in the US generics space.
C_R_COURSEWORK_AMBIKA_SHEVADE.docx (1)
Pfizer and Ranbaxy were sued for allegedly engaging in an anticompetitive scheme to delay the entry of generic Lipitor into the market. The plaintiffs claim that Pfizer and Ranbaxy agreed to delay generic Lipitor for 20 months, costing purchasers more than they would have paid for the generic version. As a result of the delayed entry, which was not until November 2011, the plaintiffs and others were forced to pay billions more for Lipitor. Both drug companies were previously sued for similar allegations of holding back the generic version in the US and then fixing its price.
The future of the pharma industry 11.07
The pharmaceutical industry is shifting away from the blockbuster drug model. Large pharmaceutical companies are using mergers and acquisitions to adapt, with some acquiring generic drug makers or biotech companies. This provides access to new markets and revenue streams but carries risks as generics have low margins. Companies are also collaborating more within the industry and beyond to innovate new business models and remain profitable in changing times.
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are generally available as tablets, capsules, powder, liquids or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts, which the probiotics market works to address.
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are generally available as tablets, capsules, powder, liquids or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts, and probiotics may help address this issue. Transparency Market Research provides business information reports and services on various sectors including pharmaceuticals, chemicals, food and beverages, and
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are generally available as tablets, capsules, powder, liquids or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts, which the probiotics market works to address.
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are referred to as probiotic supplements which are generally available as tablets, capsules, powder, liquids, or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts and diversity in the gut.
Basics of Life Science Patent Law
The document discusses various forms of intellectual property protection including patents, copyrights, trademarks, and trade secrets. Patents provide the strongest protection by giving owners the right to stop others from using their invention, but require public disclosure of how to practice the invention. Copyright and trademark protection have more limited scopes. Trade secrets do not require disclosure but can be lost if the secret becomes public. The document provides examples of intellectual property issues that commonly arise for biotech inventions and businesses.
psyllium market
Psyllium is expected to drive market growth through 2030. Transparency Market Research provides business reports and services on various industries including pharmaceuticals, chemicals, food and beverages, and technology. This report analyzes the global psyllium market from 2020 to 2030, including factors such as increasing consumer health concerns and the impact of COVID-19 on demand. Revenue from the psyllium products market was valued at $215 million in 2020 and is projected to reach $525 million by 2030, growing at a 9.2% compound annual rate.
psyllium market
Psyllium is expected to drive market growth through 2030. Transparency Market Research provides business reports and services on various industries including pharmaceuticals, chemicals, food and beverages, and technology. This report analyzes the global psyllium market from 2020 to 2030, including factors such as increasing consumer health concerns and the impact of COVID-19 on demand. Revenue from the psyllium products market was valued at $215 million in 2020 and is projected to reach $525 million by 2030, growing at a 9.2% compound annual rate.
Com^3.ppt
The document discusses strategies for a pharmaceutical company called COM^3. It considers investing in either the obesity drug market or dementia drug market. The obesity market is seen as a safer, quicker option that could double revenue to $400 million within a few years. However, the dementia drug has potential for much higher revenue of $750 million, but would require $85 million in upfront costs and 5 years before seeing a return. The company's strategy is to initially invest in obesity drugs for a safe return, while also investing in dementia to position itself for long term growth and its goal of going public by 2020.
psyllium market
Psyllium is expected to drive market growth through 2030. Transparency Market Research provides business reports and services on various industries including pharmaceuticals, chemicals, food and beverages, and technology. This report analyzes the global psyllium market from 2020 to 2030, including factors such as the COVID-19 pandemic increasing demand for safer psyllium products and concern for animal welfare leading consumers to prefer plant-based options. Revenue from the psyllium products market was valued at $215 million in 2020 and is projected to reach $525 million by 2030, growing at a 9.2% compound annual rate.
mycoprotein products market
This document discusses a report by Transparency Market Research on the mycoprotein products market. It provides an overview of TMR, which is a market research firm that produces reports on various industry sectors. The document then summarizes the table of contents for the mycoprotein products market report, which will analyze the market size and forecast for mycoprotein products globally and regionally from 2019 to 2028. It will also assess the impact of COVID-19 on the market and evaluate the market based on form, sales channel, and region.
mycoprotein products market
This document discusses a report by Transparency Market Research on the mycoprotein products market. It provides an overview of TMR, which is a market research firm that produces reports on various industry sectors. The document then summarizes the table of contents for the mycoprotein products market report, which will analyze the market size and forecast for mycoprotein products globally and regionally from 2019 to 2028. It will also assess the impact of COVID-19 on the market and evaluate the market based on form, sales channel, and region.
Curcumin market
This document summarizes a report by Transparency Market Research on the global curcumin market. It finds that the rising demand for curcumin in cosmetic, food, and pharmaceutical industries is driving market growth. Curcumin demand is increasing due to growing awareness of its anti-inflammatory and antioxidant properties. Additionally, consumer inclination toward organic products is further fueling the curcumin market. The report provides an executive summary and overview of the global curcumin market and analysis for years 2018 through 2026. It also includes market size forecasts for curcumin in regions including North America, Latin America, Europe, Japan, Asia Pacific, and the Middle East and Africa.
curcumin market
This document summarizes a report by Transparency Market Research on the global curcumin market. It finds that the rising demand for curcumin in cosmetic, food, and pharmaceutical industries is driving market growth. Curcumin demand is increasing due to growing awareness of its anti-inflammatory and antioxidant properties. Additionally, consumer inclination toward organic products is further fueling the curcumin market. The report provides an executive summary and overview of the global curcumin market and analysis for 2018-2026. It also includes market size forecasts for curcumin in various regions.
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptx
The document discusses several political, legal, and ethical dilemmas faced by the global pharmaceutical industry. It addresses questions regarding country risks, the roles of governments, branded and generic drug companies, and steps the industry is taking to increase access to medicines in developing countries. The TRIPS agreement provides intellectual property protections for pharmaceutical patents but challenges remain in ensuring these protections are carried out, particularly in developing nations. Management strategies to mitigate political and legal risks include strengthening intellectual property protections, proactively scanning the operating environment in foreign markets, and developing a more compassionate corporate image.
curcumin market
This document discusses a report on the global curcumin market published by Transparency Market Research. It provides an overview of TMR, which conducts market research and analysis. The document then summarizes the table of contents of the curcumin market report, which examines the market size and forecasts for curcumin globally and in various regions from 2018 to 2026. It also notes that rising demand from the food, cosmetic and pharmaceutical industries is driving growth in the curcumin market, as consumers are increasingly aware of its anti-inflammatory and antioxidant properties.
Discovering Digital Process Twins for What-if Analysis: a Process Mining Appr...
This webinar discusses the limitations of traditional approaches for business process simulation based on had-crafted model with restrictive assumptions. It shows how process mining techniques can be assembled together to discover high-fidelity digital twins of end-to-end processes from event data.
More Related Content
Similar to Bpl overview
2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp
This document provides information about the "2nd Pharmaceutical Anti-counterfeiting Americas" conference taking place on November 14-15, 2011 in Boston, USA. The conference will discuss combating counterfeit medicines and feature speakers from pharmaceutical companies and regulatory agencies. Attendees will learn about US policy updates, technologies for tracking pharmaceuticals, and best practices for supply chain integrity. Posters can be submitted by academic institutions, pharmaceutical companies, and service providers to share research results. The conference is aimed at professionals working in pharmaceutical supply chain security, anti-counterfeiting, brand protection, and related fields.
Biotech & Pharma Market July 2009
The document discusses opportunities in the Indian pharmaceutical and biotechnology sectors. It outlines 8 subsectors: pharmaceuticals, biopharma, contract research organizations, industrial enzymes, agribiotech, bioinformatics, diagnostics, and lab supplies. The core pharmaceutical industry focuses on small molecule drugs and generics. The biotech industry includes bio-pharma, agriculture, bioinformatics and is growing at 30% annually. The Indian pharma/biotech market was estimated at $18 billion in 2008-2009 and is projected to continue strong growth across subsectors.
Tr The Pharma Matters
The report provides an overview of the US generics drug market for the third quarter of 2009. It discusses key trends in the market including growth rates globally and in major countries. It also analyzes the companies receiving the most ANDA approvals for generic drugs and those filing the most patent challenges during this period. Teva received the most ANDA approvals while Teva continued to file the most patent challenges. The report aims to provide strategic intelligence on companies making an impact in the US generics space.
C_R_COURSEWORK_AMBIKA_SHEVADE.docx (1)
Pfizer and Ranbaxy were sued for allegedly engaging in an anticompetitive scheme to delay the entry of generic Lipitor into the market. The plaintiffs claim that Pfizer and Ranbaxy agreed to delay generic Lipitor for 20 months, costing purchasers more than they would have paid for the generic version. As a result of the delayed entry, which was not until November 2011, the plaintiffs and others were forced to pay billions more for Lipitor. Both drug companies were previously sued for similar allegations of holding back the generic version in the US and then fixing its price.
The future of the pharma industry 11.07
The pharmaceutical industry is shifting away from the blockbuster drug model. Large pharmaceutical companies are using mergers and acquisitions to adapt, with some acquiring generic drug makers or biotech companies. This provides access to new markets and revenue streams but carries risks as generics have low margins. Companies are also collaborating more within the industry and beyond to innovate new business models and remain profitable in changing times.
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are generally available as tablets, capsules, powder, liquids or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts, which the probiotics market works to address.
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are generally available as tablets, capsules, powder, liquids or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts, and probiotics may help address this issue. Transparency Market Research provides business information reports and services on various sectors including pharmaceuticals, chemicals, food and beverages, and
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are generally available as tablets, capsules, powder, liquids or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts, which the probiotics market works to address.
probiotics market
The document summarizes a report from Transparency Market Research on the probiotics market. It discusses that the global probiotics market was valued at around $6.7 billion in 2018 and is expected to grow at a CAGR of 8.3% through 2026 to be worth approximately $12.8 billion. Probiotics, when consumed by humans in non-food forms like supplements, are referred to as probiotic supplements which are generally available as tablets, capsules, powder, liquids, or chewables. Excessive antibiotic use can imbalance gut microbiota and lower bacterial counts and diversity in the gut.
Basics of Life Science Patent Law
The document discusses various forms of intellectual property protection including patents, copyrights, trademarks, and trade secrets. Patents provide the strongest protection by giving owners the right to stop others from using their invention, but require public disclosure of how to practice the invention. Copyright and trademark protection have more limited scopes. Trade secrets do not require disclosure but can be lost if the secret becomes public. The document provides examples of intellectual property issues that commonly arise for biotech inventions and businesses.
psyllium market
Psyllium is expected to drive market growth through 2030. Transparency Market Research provides business reports and services on various industries including pharmaceuticals, chemicals, food and beverages, and technology. This report analyzes the global psyllium market from 2020 to 2030, including factors such as increasing consumer health concerns and the impact of COVID-19 on demand. Revenue from the psyllium products market was valued at $215 million in 2020 and is projected to reach $525 million by 2030, growing at a 9.2% compound annual rate.
psyllium market
Psyllium is expected to drive market growth through 2030. Transparency Market Research provides business reports and services on various industries including pharmaceuticals, chemicals, food and beverages, and technology. This report analyzes the global psyllium market from 2020 to 2030, including factors such as increasing consumer health concerns and the impact of COVID-19 on demand. Revenue from the psyllium products market was valued at $215 million in 2020 and is projected to reach $525 million by 2030, growing at a 9.2% compound annual rate.
Com^3.ppt
The document discusses strategies for a pharmaceutical company called COM^3. It considers investing in either the obesity drug market or dementia drug market. The obesity market is seen as a safer, quicker option that could double revenue to $400 million within a few years. However, the dementia drug has potential for much higher revenue of $750 million, but would require $85 million in upfront costs and 5 years before seeing a return. The company's strategy is to initially invest in obesity drugs for a safe return, while also investing in dementia to position itself for long term growth and its goal of going public by 2020.
psyllium market
Psyllium is expected to drive market growth through 2030. Transparency Market Research provides business reports and services on various industries including pharmaceuticals, chemicals, food and beverages, and technology. This report analyzes the global psyllium market from 2020 to 2030, including factors such as the COVID-19 pandemic increasing demand for safer psyllium products and concern for animal welfare leading consumers to prefer plant-based options. Revenue from the psyllium products market was valued at $215 million in 2020 and is projected to reach $525 million by 2030, growing at a 9.2% compound annual rate.
mycoprotein products market
This document discusses a report by Transparency Market Research on the mycoprotein products market. It provides an overview of TMR, which is a market research firm that produces reports on various industry sectors. The document then summarizes the table of contents for the mycoprotein products market report, which will analyze the market size and forecast for mycoprotein products globally and regionally from 2019 to 2028. It will also assess the impact of COVID-19 on the market and evaluate the market based on form, sales channel, and region.
mycoprotein products market
This document discusses a report by Transparency Market Research on the mycoprotein products market. It provides an overview of TMR, which is a market research firm that produces reports on various industry sectors. The document then summarizes the table of contents for the mycoprotein products market report, which will analyze the market size and forecast for mycoprotein products globally and regionally from 2019 to 2028. It will also assess the impact of COVID-19 on the market and evaluate the market based on form, sales channel, and region.
Curcumin market
This document summarizes a report by Transparency Market Research on the global curcumin market. It finds that the rising demand for curcumin in cosmetic, food, and pharmaceutical industries is driving market growth. Curcumin demand is increasing due to growing awareness of its anti-inflammatory and antioxidant properties. Additionally, consumer inclination toward organic products is further fueling the curcumin market. The report provides an executive summary and overview of the global curcumin market and analysis for years 2018 through 2026. It also includes market size forecasts for curcumin in regions including North America, Latin America, Europe, Japan, Asia Pacific, and the Middle East and Africa.
curcumin market
This document summarizes a report by Transparency Market Research on the global curcumin market. It finds that the rising demand for curcumin in cosmetic, food, and pharmaceutical industries is driving market growth. Curcumin demand is increasing due to growing awareness of its anti-inflammatory and antioxidant properties. Additionally, consumer inclination toward organic products is further fueling the curcumin market. The report provides an executive summary and overview of the global curcumin market and analysis for 2018-2026. It also includes market size forecasts for curcumin in various regions.
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptx
The document discusses several political, legal, and ethical dilemmas faced by the global pharmaceutical industry. It addresses questions regarding country risks, the roles of governments, branded and generic drug companies, and steps the industry is taking to increase access to medicines in developing countries. The TRIPS agreement provides intellectual property protections for pharmaceutical patents but challenges remain in ensuring these protections are carried out, particularly in developing nations. Management strategies to mitigate political and legal risks include strengthening intellectual property protections, proactively scanning the operating environment in foreign markets, and developing a more compassionate corporate image.
curcumin market
This document discusses a report on the global curcumin market published by Transparency Market Research. It provides an overview of TMR, which conducts market research and analysis. The document then summarizes the table of contents of the curcumin market report, which examines the market size and forecasts for curcumin globally and in various regions from 2018 to 2026. It also notes that rising demand from the food, cosmetic and pharmaceutical industries is driving growth in the curcumin market, as consumers are increasingly aware of its anti-inflammatory and antioxidant properties.
Similar to Bpl overview (20)
2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp
2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptx
Political Legal & Ethical Dilemmas in the Pharmaceutical.pptx
Recently uploaded
Discovering Digital Process Twins for What-if Analysis: a Process Mining Appr...
This webinar discusses the limitations of traditional approaches for business process simulation based on had-crafted model with restrictive assumptions. It shows how process mining techniques can be assembled together to discover high-fidelity digital twins of end-to-end processes from event data.
一比一原版斯威本理工大学毕业证（swinburne毕业证）如何办理
原版一模一样【微信：741003700 】【斯威本理工大学毕业证（swinburne毕业证）成绩单】【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
办理斯威本理工大学毕业证（swinburne毕业证）【微信：741003700 】外观非常简单，由纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理斯威本理工大学毕业证（swinburne毕业证）【微信：741003700 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理斯威本理工大学毕业证（swinburne毕业证）【微信：741003700 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理斯威本理工大学毕业证（swinburne毕业证）【微信：741003700 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
原版制作(unimelb毕业证书)墨尔本大学毕业证Offer一模一样
学校原件一模一样【微信：741003700 】《(unimelb毕业证书)墨尔本大学毕业证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
一比一原版南昆士兰大学毕业证如何办理
原版一模一样【微信：741003700 】【南昆士兰大学毕业证成绩单】【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
办理南昆士兰大学毕业证【微信：741003700 】外观非常简单，由纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理南昆士兰大学毕业证【微信：741003700 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理南昆士兰大学毕业证【微信：741003700 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理南昆士兰大学毕业证【微信：741003700 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
一比一原版(UO毕业证)渥太华大学毕业证如何办理
原件一模一样【微信：95270640】【渥太华大学毕业证UO学位证成绩单】【微信：95270640】（留信学历认证永久存档查询）采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信：95270640】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信：95270640】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份【微信：95270640】
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
→ 【关于价格问题（保证一手价格）
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：可来公司面谈，可签订合同，会陪同客户一起到教育部认证窗口递交认证材料，客户在教育部官方认证查询网站查询到认证通过结果后付款，不成功不收费！
办理渥太华大学毕业证毕业证offerUO学位证【微信：95270640 】外观非常精致，由特殊纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理渥太华大学毕业证UO学位证毕业证offer【微信：95270640 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理渥太华大学毕业证毕业证offerUO学位证【微信：95270640 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理渥太华大学毕业证毕业证offerUO学位证【微信：95270640 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
一比一原版兰加拉学院毕业证(Langara毕业证书)学历如何办理
原版办【微信号:BYZS866】【兰加拉学院毕业证(Langara毕业证书)】【微信号:BYZS866】《成绩单、外壳、雅思、offer、真实留信官方学历认证（永久存档/真实可查）》采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【我们承诺采用的是学校原版纸张（纸质、底色、纹路）我们拥有全套进口原装设备，特殊工艺都是采用不同机器制作，仿真度基本可以达到100%，所有工艺效果都可提前给客户展示，不满意可以根据客户要求进行调整，直到满意为止！】
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信号BYZS866】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信号BYZS866】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
留信网服务项目：
1、留学生专业人才库服务（留信分析）
2、国（境）学习人员提供就业推荐信服务
3、留学人员区块链存储服务
【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：客户在留信官方认证查询网站查询到认证通过结果后付款，不成功不收费！
一比一原版爱尔兰都柏林大学毕业证(本硕）ucd学位证书如何办理
原版一模一样【微信：741003700 】【爱尔兰都柏林大学毕业证(本硕）ucd成绩单】【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
办理爱尔兰都柏林大学毕业证(本硕）ucd学位证书【微信：741003700 】外观非常简单，由纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理爱尔兰都柏林大学毕业证(本硕）ucd学位证书【微信：741003700 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理爱尔兰都柏林大学毕业证(本硕）ucd学位证书【微信：741003700 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理爱尔兰都柏林大学毕业证(本硕）ucd学位证书【微信：741003700 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
一比一原版(uom毕业证书)曼彻斯特大学毕业证如何办理
原版一模一样【微信：741003700 】【(uom毕业证书)曼彻斯特大学毕业证成绩单】【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
办理(uom毕业证书)曼彻斯特大学毕业证【微信：741003700 】外观非常简单，由纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理(uom毕业证书)曼彻斯特大学毕业证【微信：741003700 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理(uom毕业证书)曼彻斯特大学毕业证【微信：741003700 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理(uom毕业证书)曼彻斯特大学毕业证【微信：741003700 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
一比一原版莱斯大学毕业证（rice毕业证）如何办理
原版一模一样【微信：741003700 】【莱斯大学毕业证（rice毕业证）成绩单】【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
办理莱斯大学毕业证（rice毕业证）【微信：741003700 】外观非常简单，由纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理莱斯大学毕业证（rice毕业证）【微信：741003700 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理莱斯大学毕业证（rice毕业证）【微信：741003700 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理莱斯大学毕业证（rice毕业证）【微信：741003700 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
DSSML24_tspann_CodelessGenerativeAIPipelines
Codeless Generative AI Pipelines
(GenAI with Milvus)
https://ml.dssconf.pl/user.html#!/lecture/DSSML24-041a/rate
Discover the potential of real-time streaming in the context of GenAI as we delve into the intricacies of Apache NiFi and its capabilities. Learn how this tool can significantly simplify the data engineering workflow for GenAI applications, allowing you to focus on the creative aspects rather than the technical complexities. I will guide you through practical examples and use cases, showing the impact of automation on prompt building. From data ingestion to transformation and delivery, witness how Apache NiFi streamlines the entire pipeline, ensuring a smooth and hassle-free experience.
Timothy Spann
https://www.youtube.com/@FLaNK-Stack
https://medium.com/@tspann
https://www.datainmotion.dev/
milvus, unstructured data, vector database, zilliz, cloud, vectors, python, deep learning, generative ai, genai, nifi, kafka, flink, streaming, iot, edge
一比一原版马来西亚博特拉大学毕业证（upm毕业证）如何办理
原版一模一样【微信：741003700 】【马来西亚博特拉大学毕业证（upm毕业证）成绩单】【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
办理马来西亚博特拉大学毕业证（upm毕业证）【微信：741003700 】外观非常简单，由纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理马来西亚博特拉大学毕业证（upm毕业证）【微信：741003700 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理马来西亚博特拉大学毕业证（upm毕业证）【微信：741003700 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理马来西亚博特拉大学毕业证（upm毕业证）【微信：741003700 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
一比一原版(UofT毕业证)多伦多大学毕业证如何办理
原件一模一样【微信：95270640】【多伦多大学毕业证UofT学位证成绩单】【微信：95270640】（留信学历认证永久存档查询）采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信：95270640】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信：95270640】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份【微信：95270640】
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
→ 【关于价格问题（保证一手价格）
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：可来公司面谈，可签订合同，会陪同客户一起到教育部认证窗口递交认证材料，客户在教育部官方认证查询网站查询到认证通过结果后付款，不成功不收费！
办理多伦多大学毕业证毕业证假文凭UofT学位证【微信：95270640 】外观非常精致，由特殊纸质材料制成，上面印有校徽、校名、毕业生姓名、专业等信息。
办理多伦多大学毕业证UofT学位证毕业证假文凭【微信：95270640 】格式相对统一，各专业都有相应的模板。通常包括以下部分：
校徽：象征着学校的荣誉和传承。
校名:学校英文全称
授予学位：本部分将注明获得的具体学位名称。
毕业生姓名：这是最重要的信息之一，标志着该证书是由特定人员获得的。
颁发日期：这是毕业正式生效的时间，也代表着毕业生学业的结束。
其他信息：根据不同的专业和学位，可能会有一些特定的信息或章节。
办理多伦多大学毕业证毕业证假文凭UofT学位证【微信：95270640 】价值很高，需要妥善保管。一般来说，应放置在安全、干燥、防潮的地方，避免长时间暴露在阳光下。如需使用，最好使用复印件而不是原件，以免丢失。
综上所述，办理多伦多大学毕业证毕业证假文凭UofT学位证【微信：95270640 】是证明身份和学历的高价值文件。外观简单庄重，格式统一，包括重要的个人信息和发布日期。对持有人来说，妥善保管是非常重要的。
原版一比一爱尔兰都柏林大学毕业证(UCD毕业证书)如何办理
原版制作【微信:41543339】【爱尔兰都柏林大学毕业证(UCD毕业证书)】【微信:41543339】《成绩单、外壳、雅思、offer、真实留信官方学历认证（永久存档/真实可查）》采用学校原版纸张、特殊工艺完全按照原版一比一制作（包括：隐形水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠，文字图案浮雕，激光镭射，紫外荧光，温感，复印防伪）行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备，十五年致力于帮助留学生解决难题，业务范围有加拿大、英国、澳洲、韩国、美国、新加坡，新西兰等学历材料，包您满意。
【我们承诺采用的是学校原版纸张（纸质、底色、纹路）我们拥有全套进口原装设备，特殊工艺都是采用不同机器制作，仿真度基本可以达到100%，所有工艺效果都可提前给客户展示，不满意可以根据客户要求进行调整，直到满意为止！】
【业务选择办理准则】
一、工作未确定，回国需先给父母、亲戚朋友看下文凭的情况，办理一份就读学校的毕业证【微信41543339】文凭即可
二、回国进私企、外企、自己做生意的情况，这些单位是不查询毕业证真伪的，而且国内没有渠道去查询国外文凭的真假，也不需要提供真实教育部认证。鉴于此，办理一份毕业证【微信41543339】即可
三、进国企，银行，事业单位，考公务员等等，这些单位是必需要提供真实教育部认证的，办理教育部认证所需资料众多且烦琐，所有材料您都必须提供原件，我们凭借丰富的经验，快捷的绿色通道帮您快速整合材料，让您少走弯路。
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
留信网服务项目：
1、留学生专业人才库服务（留信分析）
2、国（境）学习人员提供就业推荐信服务
3、留学人员区块链存储服务
【关于价格问题（保证一手价格）】
我们所定的价格是非常合理的，而且我们现在做得单子大多数都是代理和回头客户介绍的所以一般现在有新的单子 我给客户的都是第一手的代理价格，因为我想坦诚对待大家 不想跟大家在价格方面浪费时间
对于老客户或者被老客户介绍过来的朋友，我们都会适当给一些优惠。
选择实体注册公司办理，更放心，更安全！我们的承诺：客户在留信官方认证查询网站查询到认证通过结果后付款，不成功不收费！
Recently uploaded (20)
Discovering Digital Process Twins for What-if Analysis: a Process Mining Appr...
Discovering Digital Process Twins for What-if Analysis: a Process Mining Appr...
DATA COMMS-NETWORKS YR2 lecture 08 NAT & CLOUD.docx
DATA COMMS-NETWORKS YR2 lecture 08 NAT & CLOUD.docx
Digital Marketing Performance Marketing Sample .pdf
Digital Marketing Performance Marketing Sample .pdf
A gentle exploration of Retrieval Augmented Generation
A gentle exploration of Retrieval Augmented Generation
Bpl overview
- 2. 2 The Edge for Valuing Biopharmaceuticals™ 2 The Edge for ValuingBiopharmaceuticals™
- 3. www.biopharmapatent.com October 30, 2018 Not Necessarily. Uncertainties around line extensions, competitive threats and patent expiries can drive substantially different opinions on the potential of individual products. Revlimid® has a huge $11.5bn spread between the lowest and highest 2024 sell-side sales forecast. By the time a blockbuster drug launches, there’s a pretty clear consensus view of its potential. Right?
- 4. When Generics Hit the Market, The Price of Branded Drugs Decrease Precipitously www.biopharmapatent.com
- 5. Because Generics Can Enter the Market Sooner if Protective Patents are Invalidated- Drug Patent Challenges are on the Rise 5 IN DISTRICT COURTS IN THE PATENT & TRADEMARK OFFICE
- 6. BioPharma Patent Landscapes™ Provides On- Demand Reports of the Patents/Exclusivities Protecting Biopharmaceuticals www.biopharmapatent.com
- 7. Types of Reports: • Loss of Exclusivity (LOE) When will the patents & exclusivities protecting a drug expire? • Freedom to Operate (FTO) Which 3rd party patents may be Infringed by commercializing a drug? • Investor Assurance Identifying all patents & exclusivities protecting a drug & when each expires. www.biopharmapatent.com
- 8. BPL Has Created and Maintains a Proprietary Drug Protections Database™ www.biopharmapatent.com
- 9. For Each Drug, The Database Tracks: www.biopharmapatent.com Exclusivities (data, orphan, NCE) Patents Calculated Expiration Dates Claims Summarized Patent Challenges (District Court/USPTO) FDA Approvals Original Supplementary Follow-ons/Competitors General info. Sponsor Disease Category Target Annual Sales
- 10. The Drug Protections Database® Can Be Mined To Generate Landscape Reports www.biopharmapatent.com
- 11. Expiration Dates of Patents & Exclusivities Are Visualized in Bar Graphs www.biopharmapatent.com
- 12. The Claims of Each Patent & Type of Exclusivity Are Summarized www.biopharmapatent.com
- 13. The Drug Protections Database™ Continues to Grow • Patents/exclusivities protecting FDA approved biologics (CDER & CBER). Updated as new biologics are approved. • Orange Book data imported for FDA approved pharmaceuticals. • Patents/exclusivities on biopharmaceuticals in development www.biopharmapatent.com
- 14. Invaluable Competitive Intelligence LOE & FTO Approved Drugs & Drugs in Development Constantly Updated Unique Insights Powerful Analytics www.biopharmapatent.com
- 15. Critical Data For Biopharma Decision Makers www.biopharmapatent.com BioPharma Patent Landscapes Companies Investors/ Analysts Patent Litigation Firms
- 16. What Do You Need? b.arnold@biopharmapatent.com LOE on a drug or drug pipeline FTO for a drug in development Visualization of established protections for investors
Editor's Notes
- By Drug